Cellular Products Laboratory

Cellular Products Laboratory (CPL) is a GLP-compliant contract research organization (CRO) specializing in cellular immune monitoring and assay development. As the laboratory services division of Cellular Technology Limited (CTL), which was acquired by Antylia Scientific in 2021, CPL provides standardized ELISPOT and FluoroSpot testing to support clinical trials in vaccine development, oncology, and infectious diseases. The company offers a comprehensive suite of services, including PBMC processing, cryopreservation, and high-throughput immune monitoring under strict regulatory standards. CPL is recognized for its expertise in measuring T cell and B cell responses, helping global pharmaceutical and biotechnology clients validate the immunogenicity and efficacy of their therapeutic candidates. Its facilities are optimized for large-scale clinical trial support, ensuring reproducible and high-quality data for regulatory submissions.